Morphology, MYCN Amplification and their Correlation to Survival in Neuroblastoma Patients in India

被引:0
|
作者
Srinivasan, R. [1 ,2 ]
Bhardwaj, N. [1 ]
Trehan, A. [3 ]
Rohilla, M. [2 ]
Bansal, D. [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Pathol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Pathol Cytol & Gynec Pathol Div, Chandigarh, India
[3] PGIMER, Paediat Hematol Oncol, Chandigarh, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PV0156
引用
收藏
页码:S228 / S228
页数:1
相关论文
共 50 条
  • [2] Characteristics and outcome of neuroblastoma patients with MYCN amplification
    Drozynska, Elzbieta
    Drozynska, Elzbieta
    Izycka-Swieszewska, Ewa
    Kardas, Iwona
    Stefanowicz, Joanna
    Balcerska, Anna
    Bien, Ewa
    Polczynska, Katarzyna
    Stachowicz, Teresa
    Szolkiewicz, Anna
    Stolarska, Malgorzata
    Reiter, Marta
    Koltan, Sylvia
    Wysocki, Mariusz
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 478 - 479
  • [3] MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma
    Bhardwaj, Neha
    Rohilla, Manish
    Trehan, Amita
    Bansal, Deepak
    Kakkar, Nandita
    Srinivasan, Radhika
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (09) : 599 - 605
  • [4] Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
    Kaneko, M
    Tsuchida, Y
    Mugishima, H
    Ohnuma, N
    Yamamoto, K
    Kawa, K
    Iwafuchi, M
    Sawada, T
    Suita, S
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (08) : 613 - 621
  • [5] ALK Protein Expression in Neuroblastoma and its Correlation to Morphology, MYCN Amplification, Outcome and Potential Value in Risk Stratification
    Bhardwaj, N.
    Srinivasan, R.
    Trehan, A.
    Bansal, D.
    Rohilla, M.
    Kakkar, N.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S219 - S219
  • [6] Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma
    Combaret, V
    Bergeron, C
    Noguera, R
    Iacono, I
    Puisieux, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8919 - 8920
  • [7] MYCN AMPLIFICATION DOES NOT AFFECT SURVIVAL OF NEUROBLASTOMA PATIENTS TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SANSONE, R
    DIMARTINO, D
    LANINO, E
    DINI, G
    MASSIMO, L
    TONINI, GP
    [J]. BONE MARROW TRANSPLANTATION, 1991, 7 : 133 - 135
  • [8] Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
    Berbegall, Ana P.
    Bogen, Dominik
    Poetschger, Ulrike
    Beiske, Klaus
    Bown, Nick
    Combaret, Valerie
    Defferrari, Raffaella
    Jeison, Marta
    Mazzocco, Katia
    Varesio, Luigi
    Vicha, Ales
    Ash, Shifra
    Castel, Victoria
    Coze, Carole
    Ladenstein, Ruth
    Owens, Cormac
    Papadakis, Vassilios
    Ruud, Ellen
    Amann, Gabriele
    Sementa, Angela R.
    Navarro, Samuel
    Ambros, Peter F.
    Noguera, Rosa
    Ambros, Inge M.
    [J]. BRITISH JOURNAL OF CANCER, 2018, 118 (11) : 1502 - 1512
  • [9] Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
    Ana P. Berbegall
    Dominik Bogen
    Ulrike Pötschger
    Klaus Beiske
    Nick Bown
    Valérie Combaret
    Raffaella Defferrari
    Marta Jeison
    Katia Mazzocco
    Luigi Varesio
    Ales Vicha
    Shifra Ash
    Victoria Castel
    Carole Coze
    Ruth Ladenstein
    Cormac Owens
    Vassilios Papadakis
    Ellen Ruud
    Gabriele Amann
    Angela R. Sementa
    Samuel Navarro
    Peter F. Ambros
    Rosa Noguera
    Inge M. Ambros
    [J]. British Journal of Cancer, 2018, 118 : 1502 - 1512
  • [10] Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
    Lee, Ji Won
    Son, Meong Hi
    Cho, Hee Won
    Ma, Young Eun
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 (10)